"Bat Lady" Research Team In Wuhan 'Find' COVID-Like Virus That Can Infect Humans
Chinese researchers, led by a virologist whose work had fueled concerns about a possible COVID-19 lab leak, have discovered a new bat coronavirus that is similar to the one that causes COVID-19, and that is capable of infecting humans.
The virus, called HKU5-CoV-2, can enter human cells through the ACE2 receptor, the same gateway for the SARS-CoV-2 virus that sparked a global pandemic five years ago, according to a study recently published in the peer-reviewed scientific journal Cell.
The lead researcher is Shi Zhengli, who, for years, led work on bat coronaviruses at the Wuhan Institute of Virology, a lab that has been under scrutiny amid ongoing questions about the origins of COVID-19.
The researchers collected nearly 1,000 anal swabs from pipistrellus bats across five Chinese provinces and took them to the state-owned Wuhan research institute.
The virus belongs to a distinct lineage of coronaviruses that also include the Middle East Respiratory Syndrome virus. Lab experiments indicate this virus strain may infect a wide range of mammals. The HKU5-CoV-2 has the potential to jump from one species to another, researchers said, noting the recent detection of viral sequences closely related to HKU5-CoV in farmed minks.
The virus doesn't enter human cells as readily as the SARS-CoV-2 virus, suggesting the risk of its 'emergence in human populations should not be exaggerated,' the paper states. The researchers also identified antibodies and antiviral drugs that target the virus.
Findings about the virus raised concerns from Richard Ebright, a molecular biologist and laboratory director at Rutgers University's Waksman Institute of Microbiology, who has been critical of the Wuhan Institute's virus experiments.
'In nature, this virus poses minimal threat to humans,' he told The Epoch Times on Feb. 25.
'However, [with] laboratory enhancement of transmissibility or pathogenicity, this virus could create a highly extremely threatening new bioweapons agent and pandemic pathogen.'
China is currently experiencing a surge of human metapneumovirus cases while the regime continues to resist international probes of the origin of COVID-19.
In January, the CIA became the third U.S. executive agency to back the theory that the SARS-CoV-2 virus might have come from a Chinese lab.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Insider
a day ago
- Gulf Insider
More Fetal Losses Than Expected After Pfizer COVID-19 Vaccination In Israel: Study
A higher-than-expected number of miscarriages and other forms of fetal loss were associated with COVID-19 vaccinations in Israel, a new study has revealed. Researchers found 13 fetal losses—four more than the nine expected—for every 100 pregnant women who received a COVID-19 vaccine during weeks eight to 13 in pregnancy, according to the study, which was published as a preprint on the medRxiv server. Most people in Israel, including pregnant women, received the Pfizer-BioNTech COVID-19 vaccine. Pfizer did not respond by publication time to a request for comment. The team behind the study includes Retsef Levi, a Massachusetts Institute of Technology researcher who was recently named to the committee that advises the Centers for Disease Control and Prevention on vaccines, and Dr. Tracy Hoeg, who works for the Food and Drug Administration. The researchers analyzed electronic health records from Maccabi Healthcare Services, one of four organizations that provide health care to Israelis. They looked at 226,395 pregnancies that occurred between March 1, 2016, and Feb. 28, 2022. The primary analysis looked at fetal loss for pregnant women after dose one or dose three of a COVID-19 vaccine, with fetal loss including miscarriage, abortion, and stillbirth. The researchers came up with an expected number of fetal losses based on a model that drew from data before the COVID-19 pandemic, then compared the expected number of fetal losses with those that occurred from week eight of pregnancy onward. They identified 13,214 fetal losses after the COVID-19 pandemic started, compared with 12,846 fetal losses in the reference period, finding that women who received a COVID-19 vaccine during weeks eight to 13 in pregnancy experienced a higher-than-expected number of fetal losses. 'If you believe this result … every 100 women that you would vaccinate during weeks eight to 13, you are going to see close to four additional fetal losses,' Levi told The Epoch Times. The researchers cautioned that more information is required to say for sure that the vaccines cause fetal losses. They also noted that when they carried out the same analysis for pregnant women who received a COVID-19 vaccine during weeks 14 to 27, the number of fetal losses was lower than expected. An additional analysis of pregnant women who received an influenza vaccine from March 1, 2018, to Feb. 28, 2019, also found a lower-than-expected number of fetal losses. The researchers said those results could stem from what is known as healthy vaccine bias—the data could be skewed because people who receive vaccines are typically healthier than those who do not. Maccabi Healthcare Services did not return an inquiry by publication time. Dr. Yaakov Segal, head of obstetrics and gynecology medicine at the organization, is one of the paper's co-authors. Israel's Ministry of Health and the American College of Obstetricians and Gynecologists, which encourages pregnant women to receive a COVID-19 vaccine in any trimester, did not respond to requests for comment by publication time. 'Generally, medical advice to pregnant women follows the precautionary principle and is based on sound and careful research,' Josh Guetzkow, researcher with Hebrew University of Jerusalem and another study co-author, told The Epoch Times via email. 'Our study shows just how irresponsible it was for our health authorities to abandon these core principles.' COVID-19 vaccination was recommended for pregnant women in Israel and the United States early in the COVID-19 pandemic, even though the clinical trials for the vaccines excluded pregnant women. Moderna's clinical trial for pregnant women was ultimately terminated, while Pfizer ended its trial early after enrolling just 175 women. The latter found slightly lower COVID-19 incidence among the vaccinated when compared with those who received a placebo. Some observational studies have determined that pregnant women benefit from COVID-19 vaccination. The Centers for Disease Control and Prevention recently narrowed its COVID-19 vaccine recommendations and no longer advises COVID-19 vaccination during pregnancy. The new paper was published as a preprint, without peer review. Levi said the paper had been rejected by two journals, and the authors decided that the implications were too important to continue to not release it to the public. Guetzkow said the researchers are going to keep trying to get the paper published by a journal.
Gulf Insider
18-06-2025
- Gulf Insider
Why Have Any COVID-19 Vaccines, 2025?
Five years on, SARS–CoV–2 is a ghost. It's not the beast it was (or was purported to be); yet (as of this last 'flu season') young medical students were still required to get the 'jab.' The current iteration of coronavirus, Omicron, LP.8.1–feels like a cold now, nothing more – moreover, its epitope is not even included in the 'bivalent' Covid vaccine handed out, 2025. Prior to 2003's SARS, coronaviruses were just that: colds, the kind you shook off with soup and sleep. No one demanded shots. No one cared. So why are we still doing this? The numbers, the past, the plain truth say it's hollow—a rule for the sake of rules. Back in 2020, the virus (or the overreaction to it) hit like a storm. Hospitals were packed. People died–350,000 in the US, mostly old, mostly sick – either 'from' or 'with' coronavirus. Kids? They were fine. The American Academy of Pediatrics counted 112 deaths under 18 by December—0.005% of cases; however, those children had problems: diabetes, obesity, and bad lungs. Healthy ones sneezed and moved on. Medical students, in their 20s, were close behind. The CDC pegged that age group's mortality rate at 0.02%–1,200 out of 6 million cases. Two percent landed in hospitals; near zero needed ICUs. There was no real danger for them, 2020 – and beyond. Now it's 2025. The virus hasn't vanished, but it's weak. Immunity—from shots, or from previously having contracted one or another of the Covid variant strains–covers essentially everyone. The current Omicron virus is no monster. It's a nuisance– moreover, it's likely conflated with background 'common cold' coronavirus. Omicron showed up in 2021, spread like crazy, but didn't hit hard. My 2022 piece 'Is it Time to Accept That Omicron is not COVID-19?' noted it was not even genomically and offspring of Covid-19—just another coronavirus, like the ones that give you a runny nose. The current version is much weaker. So what's the reason for medical students' 'booster' mandates' continuation? The shots aren't harmless. Myocarditis hits young guys–1–10 per 100,000 mRNA doses, says a 2022 JAMA study. Medical schools, in particular, should know better. They should move away from anachronistic, lockstep, doctrinaire mandates. In February 2025, President Trump signed an Executive Order prohibiting federal funding for educational institutions that mandate Covid–19 vaccines for in–person attendance. Medical schools reliant on federal funds may reconsider these pointless mandates, paeans to outdated orthodoxy.
Daily Tribune
18-06-2025
- Daily Tribune
‘COVID Legacy Powers Safety'
TDT | Manama Bahrain's handling of the COVID-19 pandemic has laid the foundation for a far-reaching transformation in civil protection and crisis governance, according to a senior lawmaker. MP Dr. Maryam Al-Dhaen said the Kingdom's pandemic response had demonstrated how trust, innovation, and citizen participation could be channelled into a long-term national safety strategy. That experience, she noted, has now evolved into an integrated civil defence model focused on readiness, technology, and shared responsibility. She pointed to current efforts that embed digital tools into emergency response frameworks, while simultaneously empowering society at large to play a greater role in public safety. Smart tools, safer citizens One of the most visible changes is the rollout of the 'BeAware Bahrain' mobile application, which offers users real-time alerts, safety guidance, and interactive support in emergency scenarios. Dr. Al-Dhaen described the app as a key part of Bahrain's shift from reactive crisis response to proactive community protection. Complementing the app is the National Civil Protection Platform, an institutional framework designed to unify state and community efforts under a common strategy. The platform, she said, reinforces Bahrain's advanced security culture and promotes an environment of resilience and awareness. Shared responsibility The government's civil protection efforts also include expanding the scope of preparedness across different sectors. Dr. Al-Dhaen highlighted the recent civil defence training sessions conducted for Members of Parliament, calling it a clear sign that the responsibility for public safety is being shared across institutions. 'The concept of safety in Bahrain has become a shared responsibility between state institutions and society,' she said, noting that awareness campaigns and simulations have now reached multiple levels of government and civil society. Leadership and coordination Dr. Al-Dhaen credited His Majesty King Hamad bin Isa Al Khalifa for leading a crisis governance model that prioritises regional stability and domestic readiness. She also praised the active role of His Royal Highness Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister, in monitoring emergency procedures and enhancing national preparedness. She further commended the Civil Defence Council, chaired by His Excellency Lieutenant General Shaikh Rashid bin Abdullah Al Khalifa, Minister of Interior, for its role in strengthening preventive measures and coordination across agencies. In closing, Dr. Al-Dhaen said Bahrain's civil protection system today reflects the lessons of its pandemic response, turning past challenges into future safeguards.
